An RNA tumor viruses morphologically classified as type-C viruses have been associated with leukemia/lymphoma in birds, rodents, cats (1), and subhuman primates (2, 3). In human leukemia, RNA tumor viruses have yet to be convincingly demonstrated by either morphological identification or the transmission of biological activity. However, in the past three years human leukemia cells have been demonstrated to contain an RNA-directed DNA polymerase (4, 5) and RNA molecules (6, 7) with marked similarity to analogous components from RNA tumor viruses. In leukemic cells the viruslike DNA polymerase and RNA may be complexed, as determined by the endogenous synthesis of DNA with the RNA template (4-7), and they can be found in a cytoplasmic "particle" that has the density (1.14-1.17 g/ml) characteristic of RNA tumor viruses (5-7). These associated physical properties were used in the present study to separate leukemic cell RNA-directed DNA polymerase from other cellular DNA polymerases, rather than using more conventional procedures for purifying polymerase enzymes. This leukemic cytoplasmic enzyme was identical in its biochemical properties to RNAdirected DNA polymerase of mammalian type-C viruses, and as in our recent patient with acute myelogenous leukemia sucrose in an SW27 rotor and centrifuged at 98,000 X g for 1 hr. The supernatant was removed, and the pellet was evenly suspended in buffer B and used for further studies.
RNA tumor viruses morphologically classified as type-C viruses have been associated with leukemia/lymphoma in birds, rodents, cats (1) , and subhuman primates (2, 3) . In human leukemia, RNA tumor viruses have yet to be convincingly demonstrated by either morphological identification or the transmission of biological activity. However, in the past three years human leukemia cells have been demonstrated to contain an RNA-directed DNA polymerase (4, 5) and RNA molecules (6, 7) with marked similarity to analogous components from RNA tumor viruses. In leukemic cells the viruslike DNA polymerase and RNA may be complexed, as determined by the endogenous synthesis of DNA with the RNA template (4-7), and they can be found in a cytoplasmic "particle" that has the density (1.14-1.17 g/ml) characteristic of RNA tumor viruses (5-7). These associated physical properties were used in the present study to separate leukemic cell RNA-directed DNA polymerase from other cellular DNA polymerases, rather than using more conventional procedures for purifying polymerase enzymes. This leukemic cytoplasmic enzyme was identical in its biochemical properties to RNAdirected DNA polymerase of mammalian type-C viruses, and as in our recent patient with acute myelogenous leukemia (5), it was selectively inhibited by antisera to RNA-directed DNA polymerase of certain primate type-C viruses. Further, such antisera have failed to inhibit the two major DNAdirected DNA polymerases and the so-called "R-DNA" polymerase (8) from normal and leukemic human leukocytes (5 and see text). These findings suggest that antisera to RNAdirected DNA polymerase of certain primate type-C viruses represent specific and potentially sensitive probes for detecting and for determining the cellular distribution of RNAdirected DNA polymerase of human leukemic cells.
MATERIALS AND METHODS
Source of Cells. Patient C.P. (designated HL-8) is a 69-yearold caucasian male with a diagnosis of acute myelomonocytic leukemia. Presenting signs included gingival hypertrophy and hepatomegaly. He was anemic, and his leukocyte count was markedly increased to 250,000 per mm' (normal range 5,000 to 10,000 cells per mm'). More than 70% of the leukocytes were immature myeloid elements, although substantial numbers of mature polymorphonuclear leukocytes and occasional basophils and eosinophils were noted. The peripheral leukocytes, separated from whole blood as described (9) , were used before therapy.
Biochemical procedures
Preparation of the Cytoplasmic Pellet Fraction. The patient's leukocytes (10 g) were suspended in five volumes of buffer A (50 mM Tris * HCl, pH 7.5-5 mM MgCl2-20 mM dithiothreitol-0.5 mM EDTA) containing 0.1 M sucrose and were homogenized to approximately 75% cytoplasmic rupture in a tight-fitting Dounce homogenizer. The nuclei and mitochondria were successively removed by centrifugation for 10 min at 1,000 and 12,000 X g, respectively, in a Sorvall centrifuge. The supernatant was layered over a 10-ml column of buffer B (50 mM Tris * HCl, pH 7.5-5 mM MgCl,-0.1 M KCl- Glycerol gradient sedimentation analyses of RNAdirected DNA polymerase from murine leukemia virus and acute myelogenous leukemia cells (HI8). 0.05 ml of the viral enzyme and of the leukemic cell enzyme were each mixed with bovineserum albumin (1 mg), and each enzyme sample was applied to a 5-25% glycerol gradient. The glycerol gradients were prepared, centrifuged, and analyzed as described (10) . After centrifugation the 280-nm absorbance of each gradient fraction was determined; the arrow marks the bovine-serum albumin peak for each gradient. Aliquots (0.03-ml) were assayed in 0.10-ml reaction mixtures for 60 min at 370C with (A)n-(dT)12_18 as template (10) . RNAdirected DNA polymerase of (A) murine leukemia virus; (B) HI8.
volume of 0.05 ml, containing standard reagents for assay of The preparation of the leukemic cell enzyme from the postmitochondrial, 98,000 X g cytoplasmic pellet fraction by sucrose equilibrium density gradient centrifugation and Sepharose 4B chromatography is described in Methods.
Template-Primer Properties and Ionic Requirements. The enzyme preferred (A).* (dT)12_18 to (dA). - Estimation of Enzyme Size. Fig. 1 presents the glycerol gradient analysis of the leukemic enzyme compared to purified DNA polymerase from Rauscher leukemia virus. Both enzymes sediment in the same position relative to bovine-serum albumin, indicating an estimated molecular weight of approximately 70,000 (assuming a globular protein), which is in agreement with reports for other mammalian type-C polymerases (11, 13, 14) .
Immunologic properties of the leukemic DNA polymerase
In order to further investigate the virus-like nature of the leukemic enzyme, it was tested for inhibition by purified IgG from antisera prepared against DNA polymerases from various RNA tumor viruses. The leukemic enzyme was markedly inhibited by anti-polymerase IgG to the two known primate type-C viruses, simian sarcoma virus, derived from a woolly monkey fibrosarcoma (15) , and gibbon ape virus, derived from a gibbon ape lymphosarcoma (3) (Fig. 2) . The greater inhibition of the leukemic enzyme by the anti-polymerase IgG to simian sarcoma virus compared to anti-polymerase IgG to gibbon virus is at least partially related to the greater potency of the simian sarcoma virus, antiserum for its homologous enzyme. The leukemic DNA polymerase was not inhibited by IgG specific for DNA polymerase from another primate virus which is not a type-C virus, the Mason-Pfizer monkey virus. Also, minimal or no inhibition of the leukemic polymerase was noted with potent anti-polymerase IgG to avian sarcoma virus, mouse type-C leukemia virus, or the endogenous feline type-C virus, RD-114 (Fig. 3) .
As previously reported, DNA polymerases I and II from normal mouse (13) (16) . Like RNAdirected DNA polymerase, this enzyme preferred (A)n--(dT)12_18 to (dA)n-(dT)12_18 (6:1). However, it did not utilize (C)n (dG)12-18. When analyzed as described in the legend to Fig. 1 , it was determined to have a molecular weight of greater than 90,000, which is significantly larger than RNA-directed DNA polymerase and is in agreement with other size determinations of DNA polymerase III (11, 16 80T <10T
<10 (16) * The data presented in this table were derived in part from results presented in other reports, which are cited by the numbers in parentheses. The data presented were obtained under optimal conditions for that particular enzyme as indicated in the text or in the appropriate reference.
t The isolation of the HL-3 leukemic cytoplasmic pellet enzyme was first described in ref. 
DISCUSSION
The following properties of the RNA-directed DNA polymerase isolated from leukemic leukocytes of patient HL-8 readily distinguish it from the two known DNA-directed DNA polymerases from normal leukocytes: (1) a strong preference for the synthetic template-primer, (A)n. (dT)12_8 over (dA)n. (dT)12_18; (2) efficient utilization of (C). -(dG)12_18; (3) inhibition by antisera to RNA-directed DNA polymerase of primate type-C virus; (4) lack of inhibition by anti-DNA polymerase I IgG; and (5) estimated molecular weight of 70,000 (Table 2) . Although not available for the HL-8 enzyme, another distinguishing feature of the cytoplasmic pellet enzyme from leukemic patients is the response to 70S RNA template from RNA tumor viruses (HL-3, Table 2 ; refs. 4, 5, 17) . The HL-8 enzyme may also be distinguished from terminal deoxynucleotidyl transferase (12) , which was recently reported in the leukemic cells from one patient with acute lymphocytic leukemia (22) , since the HL-8 enzyme did not significantly catalyze the incorporation of deoxynucleoside monophosphates in the absence of template (Table 1) . By these same criteria the leukemic cytoplasmic enzyme is indistinguishable from RNA-directed DNA polymerase from primate type-C viruses (Table 2 ) and, therefore, we feel justified in referring to this enzyme as leukemic cell "reverse transcriptase." As described in Results and indicated in Table 2 , DNA polymerase III isolated from these same cells could be distinguished from the RNA-directed DNA polymerase of leukemic cells by criteria 2, 3, and 5. We previously reported partial inhibition of "R-DNA" polymerase by primate anti-polymerase IgG (5); however, in subsequent studies, including this enzyme isolated from HL-8 leukemic cells and from replicating human lymphoblastoid (NC37) culture cells (16), inhibition has not been observed. Conversely, a poly(A)-directed polymerase recently described in nonvirus-producing mouse cells was partially inhibited by antisera to RNA polymerase of murine leukemia virus (11) . Thus, although these poly(A)-directed, poly(dT)-synthesizing enzymes can be differentiated from RNA-directed DNA polymerase, they are poorly characterized at the present time and could have some relationship to viral enzyme that requires further investigation.
The studies with primate type-C virus anti-polymerase IgG in which leukemic cell RNA-directed DNA polymerase was inhibited to approximately the same extent as homologous viral RNA-directed DNA polymerase strongly suggest extensive structural homology of these enzymes. By similar reasoning, there is presumably less structural homology of the leukemic enzyme to RNA-directed DNA polymerase from lower mammalian type-C viruses or from primate nontype-C virus. This interpretation is reinforced by the following: (1) similar results were achieved with antisera prepared against RNA-directed DNA polymerase of simian sarcoma virus when the virus was obtained from three different types of cultured cells (human, marmoset, and rat) and when antisera were raised in two different animals (rabbit and rat); (2) (24) . By applying molecular probes specific for primate type-C virus molecules, as presented here and elsewhere (4, 5) , to the study of additional leukemic patients, we may be able to discriminate between these two alternatives and to further evaluate the possible etiologic role of type-C virus information in human leukemia.
